Doctors now recommend wider screening for Type 1 diabetes in children, including siblings of those already diagnosed, due to a new drug that can delay the disease's progression. The International Society for Pediatric and Adolescent Diabetes (ISPAD) has issued updated guidelines stressing the importance of early detection and the potential impact of teplizumab, a drug approved by the FDA in late 2022.
Community invited to candlelight vigil to honor life of 7-year-old Breon Allen as JSO works to solve deadly shooting
St. Augustine Black History App was launched to give users an interactive and immersive way to explore the rich black history of the city.How this app lets you immerse yourself in 450 years of St. Augustine’s rich Black history The set of guidelines covers about 20 different aspects of diabetes care and is periodically updated by ISPAD. They play a major role in guiding treatment for millions of people globally.
UF Health participates in TrialNet, an international research consortium to prevent Type 1 diabetes, and was one of the major clinical trial sites for its work on teplizumab. Doing that, he added, might require state and federal policies to incentivize physicians into entering the field.
TYPE 1 DIABETES SCREENING CHILDREN TREATMENT PEDIATRIC ENDOCRINOLOGY
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Combining Calorie Restriction and Diabetes Drug Reverses Type 2 Diabetes in Nearly Half of PatientsA new clinical trial shows that combining a moderate calorie-restricted diet with the diabetes drug dapagliflozin achieved type 2 diabetes remission in nearly 44% of participants.
Read more »
Misdiagnosed Diabetes: New Type 1.5 Diagnosis Leads to Improved HealthThis article highlights the story of Megan Metz, who was initially misdiagnosed with type 2 diabetes. After years of struggling to manage her blood sugar, she received a new diagnosis of type 1.5 diabetes, a milder form of type 1 diabetes often misidentified as type 2. This diagnosis led to a more effective treatment plan with mealtime insulin, resulting in significant improvement in her health.
Read more »
Choline Alfoscerate Improves Cognitive Function in Older Patients with Type 2 DiabetesA 12-month study found that daily treatment with 1200 mg of choline alfoscerate significantly improved cognitive function and physical health in older patients with type 2 diabetes and early signs of cognitive decline.
Read more »
Fecal Microbiota Transplantation Shows Promise for Type 1 Diabetes Gastrointestinal IssuesA new study suggests that fecal microbiota transplantation (FMT) can alleviate gastrointestinal problems in people with type 1 diabetes. Researchers at Aarhus University Hospital in Denmark found that FMT significantly reduced gastrointestinal symptoms in participants compared to a placebo group, with no major complications.
Read more »
Genetic Risk Score Predicts Type 2 Diabetes in Individuals With Normal Weight and Blood SugarA new study suggests a genetic risk score for type 2 diabetes can predict disease onset in individuals with normal weight and blood sugar levels, challenging traditional screening approaches.
Read more »
CGM Data Shows Promise in Predicting Type 1 Diabetes ComplicationsA new study reveals that continuous glucose monitors (CGM) can predict nerve, eye, and kidney damage caused by type 1 diabetes, potentially changing how doctors manage the disease and prevent life-altering complications.
Read more »